Andreas Kjær

Andreas Kjær

Professor

ORCID: 0000-0002-2706-5547

Publication year:
All
181 - 190 out of 702Page size: 10
  1. 2020
  2. Published

    P53, Somatostatin receptor 2a and Chromogranin A immunostaining as prognostic markers in high grade gastroenteropancreatic neuroendocrine neoplasms

    Nielsen, K., Binderup, Tina, Langer, Seppo W., Kjær, Andreas, Knigge, P., Grøndahl, V., Melchior, L., Federspiel, B. & Knigge, Ulrich, 2020, In: BMC Cancer. 20, 14 p., 27.

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. Published

    Pharmacokinetic analysis of [68Ga]Ga-DOTA-TOC PET in meningiomas for assessment of in vivo somatostatin receptor subtype 2

    Bashir, A., Vestergaard, M. B., Binderup, Tina, Broholm, H., Marner, Lisbeth, Ziebell, M., Fugleholm, Kåre, Mathiesen, Tiit Illimar, Kjær, Andreas & Law, Ian, 2020, In: European Journal of Nuclear Medicine and Molecular Imaging. 47, 11, p. 2577-2588

    Research output: Contribution to journal › Journal article › Research › peer-review

  4. Published

    Preclinical evaluation of cationic DOTA-triarginine-lipid conjugates for theranostic liquid brachytherapy

    Wang, W., Fliedner, F. P., Hansen, A. E., Eliasen, R., Melander, F., Kjær, Andreas, Andresen, T. L., Jensen, A. I. & Henriksen, J. R., 2020, In: Nanotheranostics. 4, 3, p. 142-155 14 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  5. Published

    Preliminary Evaluation of (S)-7-[F-18]Fluorotryptophan as a Tracer for the Imaging of Tryptophan Metabolism Alterations in Tumor Xenografts

    Hvass, L., Shalgunov, Vladimir, Jorgensen, J. T., Zlatopolskiy, B. D., Neumaier, B., Kjær, Andreas & Herth, Matthias Manfred, 2020, In: European Journal of Nuclear Medicine and Molecular Imaging. 47, SUPPL 1, p. S646-S647 Meeting Abstract: EP-282 .

    Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

  6. Published

    Quantitative PET imaging of PD-L1 expression in xenograft and syngeneic tumour models using a site-specifically labelled PD-L1 antibody

    Christensen, C., Kristensen, L. K., Alfsen, M. Z., Nielsen, Carsten Haagen & Kjær, Andreas, 2020, In: European Journal of Nuclear Medicine and Molecular Imaging. 47, 5, p. 1302-1313

    Research output: Contribution to journal › Journal article › Research › peer-review

  7. Published

    Quantitative determination of 64Cu-liposome accumulation at inflammatory and infectious sites: Potential for future theranostic system

    Clausen, Anne Skovsbo, Ostergaard, D. E., Holmberg, P., Henriksen, J. R., Tham, J., Damborg, Peter Panduro, Jensen, A., Kjær, Andreas, Hansen, A. E. & Andresen, T. L., 2020, In: Journal of Controlled Release. 327, p. 737-746

    Research output: Contribution to journal › Journal article › Research › peer-review

  8. Published

    Renal 123I-MIBG uptake before and after live-donor kidney transplantation

    Rasmussen, T., Nijs, R. D., Olsen, L. K., Kamper, A. L., Bang, L. E., Frimodt-Møller, M., Kelbæk, H., Sørensen, Søren Schwartz, Kjær, Andreas, Feldt-Rasmussen, Bo, Svendsen, Jesper Hastrup & Hasbak, P., 2020, In: Diagnostics. 10, 10, 802.

    Research output: Contribution to journal › Journal article › Research › peer-review

  9. Published

    Reproducibility of LVEF, LV volumes, and LV mass between Rubidium-82 PET/CT scans in young healthy volunteers using two commercially available software packages

    Byrne, C., Kjær, Andreas, Forman, Julie Lyng & Hasbak, P., 2020, In: Journal of Nuclear Cardiology. 27, p. 1237–1245 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  10. Published

    Rubidium-82 positron emission tomography for detection of acute doxorubicin-induced cardiac effects in lymphoma patients

    Laursen, A. H., Elming, M. B., Ripa, Rasmus Sejersten, Hasbak, P., Kjær, Andreas, Køber, Lars Valeur, Marott, J. L., Thune, J. J. & Hutchings, M., 2020, In: Journal of Nuclear Cardiology. 27, 5, p. 1698-1707

    Research output: Contribution to journal › Journal article › Research › peer-review

  11. Published

    Soluble urokinase plasminogen activator receptor (suPAR) is lower in disease-free patients but cannot rule out incident disease in patients with suspected cancer

    Rasmussen, L. J. H., Schultz, M., Iversen, Kasper, Eugen-Olsen, J., Helms, Morten, David, K., Kjær, Andreas, Lebech, Anne-Mette & Kronborg, Gitte, 2020, In: Clinical Biochemistry. 84, p. 31-37

    Research output: Contribution to journal › Journal article › Research › peer-review

Previous 1...15 16 17 18 19 20 21 22 ...71 Next

ID: 13402